The future looks bright for new atopic dermatitis treatments, according to Dr. Charles Ellis, a dermatology professor at the University of Michigan in Ann Arbor.
“I think we are at the point where...
The U.S. Food and Drug Administration has approved secukinumab for the treatment of moderate to severe plaque psoriasis in adults.
The injectable interleukin-17A inhibitor is indicated for...
The findings of a new study challenge the importance of anti–double stranded DNA antibodies as a diagnostic hallmark for lupus.
The assessment of different anti–double stranded DNA (dsDNA) antibody...
New guidelines on nail psoriasis address four clinical manifestations of the disease. The recommendations by the Medical Board of the National Psorias... More »
ORLANDO – A three-component combined over-the-counter and prescription skin care regimen was safe, effective, well tolerated, and well liked by acne... More »
ORLANDO – An over-the-counter 5.5% benzoyl peroxide preparation with lipohydroxy acid was a safe and effective alternative to prescription 5% benzoy... More »
Patients with psoriatic arthritis and psoriasis report having a better response to etanercept the earlier they are treated, according to a post hoc analysis of the PRESTA trial.
Patients with...
Eczema in adulthood is directly associated with an increase in incidence of injuries that cause physical limitations, particularly fracture, bone, and... More »
Ustekinumab treatment was associated with new-onset or worsening psoriatic arthritis in a series of seven patients with psoriasis.
The findings, which support previous observations that patients...
Case reports of unusual drug hypersensitivity to MEK inhibitors, involving skin eruptions with distinctive central duskiness, have been described onli... More »
